Topic: enabling technologies

NSF funding for startups and small businesses developing next-generation scientific instruments, experimental platforms and enabling technologies for research.

This investor-partnership competition supports late-stage development and adoption of engineered biological products and services. Eligible themes include health, food and agriculture, chemicals and materials, low-carbon fuels, waste and environment, and enabling technologies. Projects must offer a credible route to market and company growth. Grant requests range from £250,000 to £2 million for 24-month projects, with funding rates depending on business size. A designated investor must lead aligned private financing worth at least twice the grant. Applications close on 2 December 2026 at 11:00

A conference connecting fundamental cancer research from molecules and cells to tissues, organs and whole organisms. Sessions cover molecular mechanisms, enabling technologies, cell behaviour, and cancer’s interactions with immunity, metabolism and its environment. Early-career and established researchers can develop interdisciplinary collaborations; poster sessions and selected lightning talks provide opportunities to present research. Abstracts close on 30 October 2026, with decisions from 13 November. Early-bird rates ended on 11 September; standard rates apply through 27 November, followed

The sixth H3D symposium brings scientists and pharmaceutical researchers together around chemistry and biology for infectious diseases. The programme covers drug discovery, chemical biology, medicinal and synthetic chemistry, infectious-disease biology and enabling technologies, with scientific talks, posters and networking. It takes place at the Arabella Hotel, Golf and Spa outside Hermanus, South Africa, from 13 to 16 October 2026. Standard delegate registration is open until 10 October 2026. Abstract submission closed on 15 May and early registration closed on 31 July; those actions are no